Sales Specialist, Uro-Oncology - Los Angeles, CA
Ferring
About this role
Ferring is a biopharmaceutical company specializing in life-changing therapies, with a focus on innovative treatments for bladder cancer. The company values scientific progress, entrepreneurial spirit, and a people-first philosophy, aiming to improve patients' lives through advanced therapies and research.
Skills
About Ferring
ferringusa.comN/A
Recent company news
Business WireFerring Highlights New Real-World Research with ADSTILADRIN
Oct 28, 2025
BioSpaceFerring Unveils New Data with ADSTILADRIN® (nadofaragene firadenovec-vncg) at 112th Annual Meeting of the Japanese Urological Association
Apr 21, 2025
Fierce PharmaFerring opens doors to Finnish manufacturing hub as supply of its bladder cancer gene therapy continues to grow
Oct 3, 2024
Yahoo FinanceU.S. FDA Approves Second Drug Product Manufacturing Facility for ADSTILADRIN® (nadofaragene firadenovec-vncg)
Apr 24, 2025
Endpoints NewsADSTILADRIN® (nadofaragene firadenovec-vncg) – A Growing Body of Clinical Data and Real-World Evidence
Apr 21, 2025
About Ferring
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Ferring.
Salary
$120k – $170k
per year
More jobs at Ferring
Similar Jobs
Senior Oncology Specialist - SAPPHIRE- Los Angeles, CA (East
Amgen
Global Development Scientist Director
AstraZeneca
Specialty Account Manager, Auvelity (Los Angeles, CA)
Axsome Therapeutics
Associate Director, Clinical Site Partner, Clinical Operations, Oncology
Gilead Sciences
Hematology Account Manager - Overlay (Phoenix)
PharmaEssentia
Crm Senior Field Clinical Representative West Los Angeles Ca Los Angeles Us Ca United States Us Ca Los Angeles
bostonscientific